Altogether, our systematic analyses of metabolomic and transcriptomic data, as well as protein levels and creatine kinase activity measures in human WAT, demonstrate that phosphocreatine abundance is increased and that CK-B expression/activity is decreased in obesity (Fig. 1f). Here, CKB is linked to obesity disorder.